Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Booz Allen Hamilton heads into its October 23 earnings report with short sellers quietly adding positions, analysts trimming targets, and the stock down 6.4% over the past month to $68.14.
The most notable shift over the past 30 days is a 5% build in short interest. BAH's short interest now stands at 6% of free float, up from roughly 5.7% a month ago, representing around 7.3 million shares. The one-week move is modest at -0.9%, suggesting the build was steady rather than a sudden rush. That said, the borrow market remains extraordinarily loose. Availability runs at over 4,000% of short interest, meaning there are roughly 82.8 million shares available to borrow against 7.3 million currently lent out. Cost to borrow has ticked up 17.6% on the week to 0.54%, its highest level in recent months, but remains firmly in "easy borrow" territory. Options positioning is calm too. The put/call ratio of 0.83 is barely above its 20-day average of 0.82, a z-score of just 0.2, nowhere near the defensive posturing that precedes genuine fear about a print. The lending market and options market are not telling a squeeze or panic story; the positioning reads as measured caution, not alarm.
The analyst picture this week sharpens that caution. On October 7, both Citigroup and Jefferies cut their price targets, Citi to $77 from $82 and Jefferies to $75 from $80, while both held neutral or hold ratings. TD Cowen bucked the trend a day earlier, nudging its target to $77 from $75 while keeping a hold. The consensus mean target of $83.62 is roughly 23% above the current price, but the direction of recent moves has been overwhelmingly downward. Goldman Sachs carries a sell rating with a $65 target, and Bank of America has an underperform at $75. The valuation already looks compressed: EV/EBITDA is at 8.8x and the P/E is around 10.3x, both declining over the past month. The bull case rests on a roughly 10% free cash flow yield, a $38 billion backlog, and FY2027 revenue guidance of $11.2 billion to $11.7 billion. Bears point to Civil-facing contract disruptions, government pricing headwinds, and staffing constraints that could undermine the delivery model. With most of the Street parked at hold and targets drifting lower, the immediate risk is that the October 23 print fails to provide a catalyst to close the gap to consensus.
The one encouraging datapoint in the company's own activity data is retail attention. Wikipedia page views are running 1.2 standard deviations above their 90-day average, elevated relative to the stock's own recent history. That dataset has not been measured to lead BAH's financials, so it is colour rather than signal. No federal awards data has produced a measured lead against reported revenues either. The alt-data picture adds texture but no directional read on the quarter.
Institutional ownership offers some structural support. BlackRock holds 11% of shares and added 781,823 shares in the most recent reported period. T. Rowe Price holds 8.1% and added 185,000 shares. PRIMECAP filed a fresh 13G in August at 5.3%. None of these holders are on a 13D activist register, and there is no activist angle here. The insider register is quiet: the only meaningful open-market transaction in the past 90 days was a small sale of 469 shares by the VP and controller in August, worth just $36,544. Grants to directors in August are compensation mechanics rather than a conviction signal. On balance, the ownership base looks stable and slightly constructive.
The October 23 earnings event is the clearest near-term reference point. Last quarter BAH moved 8.8% higher on the day and added another leg the following week. The prior available print showed a 3.2% gain on the day and 9.9% by the five-day mark. Both reactions were positive, which stands in contrast to the current mood of target cuts and modest short rebuilding. What to watch between now and the print is whether analyst targets continue drifting lower, narrowing the gap to current prices, and whether the short interest build continues or stalls as borrow costs remain contained.
See the live data behind this article on ORTEX.
Open BAH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
